European Investment Bank's Biotechnology Portfolio

IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.

Inbiose is a B2B biotech company that develops specialty carbohydrates.

Minoryx Therapeutics offers pharmacological chaperones, which are small molecule drugs used for the treatment of genetic diseases.

ExeVir Bio is a Belgium-based company that develops single-domain antibody-based therapies that help patients ward off viral infections.

Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.

TISSIUM develops biodegradable sealants and adhesives for wound closure in the field of minimally-invasive surgery.

Priothera is developing the orally applied sphingosine 1 phosphate (S1P) receptor modulators for haematological malignancies.

Inventiva Pharma is a biopharmaceutical company with several drug candidates at clinical and preclinical stage.

TreeFrog Therapeutics is a stem cell company that will enable millions of patients to access the medical revolution of cell therapies.

OSE Immunotherapeutics is an integrated biotechnology company focused on inflammatory disease and cancer treatment.

NVision Imaging Technologies develops quantum-based medical imaging technology that enhances the capabilities of standard MRI systems.

Algorithmiq develops algorithms to solve currently inaccessible problems in life sciences.

DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition.

SDS Optic specializes in pre-assembling of hermetic and standard photoelectronics components.

GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases.

BioSenic is a forward-thinking firm that aims to address critical unmet medical needs.

Amadix is a biotechnology company focused on the development and commercialization of diagnostic tools for personalized oncology treatment.

Anocca is a clinical-stage biopharmaceutical company that develops T-cell receptors to treat infectious and autoimmune diseases.

Enterome is a clinical-stage company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.

Neuromod Devices has developed LENIRE® (www.lenire.com) a non-invasive bimodal neuromodulation therapy for tinnitus.

Nuritas combines artificial intelligence and genomics to discover and unlock natural bioactive peptides with extraordinary health benefits

Ovagen is a biotechnology company.

A innovative orthopaedic implant for the treatment of thumb base arthritis.

Stilla Technologies is a Paris-based european biotechnology company.

Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.

SamanTree Medical is an innovative Swiss company, developing a medical device to acquire tissue images during surgical cancer intervention.

Universal Diagnostics is a biotechnology firm that develops minimally invasive, blood-based solutions for the early detection of cancer.

Formo is a cell-ag company that develops animal-free dairy products using nature-identical milk proteins from precision fermentation.

In Ovo combines animal welfare and efficiency by offering biotechnological solutions to the poultry industry.

MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up.

LUMICKS provides single-molecule analysis technologies for cancer research and immunotherapy.

Overture Life is a biotechnology company that develops automated technologies for assisted reproductive procedures.

The company uses its plant-based expression technology to produce a wide range of recombinant proteins for multiple applications.

Nightingale Health is a biotechnology company transforming the prevention of chronic diseases.